[American Thoracic Society American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans - ()] C41. EMERGING PHARMACOLOGY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: MECHANISMS AND OUTCOMES - Fluticasone Furoate, A Novel Enhanced-affinity Inhaled Corticosteroid (ICS), Has More Potent Anti-inflammatory Effects Than Fluticasone Propionate In Peripheral Blood Mononuclear Cells From Asthma And COPD Patients